Phytotherapy as an alternative method to supp ort treatment of hypertension

• Authors: Piotr WYKURZ , Bożena MUSZYŃSKA
• Languages of publication: PL EO

Abstracts

EN

Hypertension is a dangerous chronic disease; it is the most common cause of death in Poland, Europe and the United States. In Poland, the estimated number of people with hypertension is about 36%. The development of this disease is progressive, a large proportion of people are unaware of their disease in the early stages. The use of basic recommendations for the prevention of hypertension i. e. stopping smoking, limiting alcohol intake and weight gain, increasing physical activity, limiting salt intake and changing eating habits can effectively lower blood pressure by 20-50 mm Hg. Such a considerable effect can significantly help a person with grade 2 hypertension (160-179 / 100-109 mm Hg). Phytotherapy is the branch of medicine that uses plants for medicinal purposes. Active compounds contained in plant raw materials can be used in heart and vascular diseases. They exhibit anti-arrhythmic, hypotensive, dilate peripheral, cerebral, coronary vessels, improving lipid profile, antioxidant, vasoprotective, antiplatelet, anti-inflammatory, immunostimulatory and diuretic. They exhibit negative chronotropic, but dromotropic and inotropic positive activity. Phytotherapy can be used as an alternative method to support the treatment of hypertension. In combination with basic preventive recommendations, it can delay the treatment by synthetic drugs for a very long time. It is therefore worth using herbs and their blends to improve the quality of our lives.

Keywords

EN

hypertension; medicinal plants in hypertension; phototherapy; prophylactic of hypertension

Discipline

• MEDICINE: MEDICINE

• Journal: Medicina Internacia Revuo
• Year: 2017
• Volume: 28
• Issue: 108
• Pages: 202-215

Contributors

author

Piotr WYKURZ

author

Bożena MUSZYŃSKA

• Department of Pharmaceutical Botany, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland

References

• 1. Lamer-Zarawska E., Kowal-Gierczak B., Niedworok J.; PZWL 2007
• 2. Jasiński M. et all; BIOTECHNOLOGIA 2 2009,85,81-94
• 3. Różański H. S.; cz.I-IV 1989-2001
• 4. Matławska I.; UMP 2008
• 5. Ożorowski A.; PZWL 1982
• 6. Ożarowski A., Jaroniewski W.; IWZZ 1987
• 7. Muszyńska B.; ZOZ 2014
• 8. Karin Ried; The Jurnal of Nutrition 2016, 389-396
• 9. Nowak G.; Herba Polonica 2009, 55(2)
• 10. Qi Chang, Zhong Zuo, Harrison F. et all; Journal of Clinical Pharmacology 2002,42,605-612
• 11. Kuźnicka B., Dziak M.; PZWL 1987
• 12. Peng X., Zhou R., Wang B. et all; Scientific Reports 2014, 6251
• 13. Yarmolinsky J., Gon G., Edwards P.; Nutr Rev 2015,73(4),236-246
• 14. Garcia M. L., Pontes R. B., Nishi E. E.; Journal of Hypertension 2017,35(2),348–354
• 15. Onakpoyaa I., Spencera E., Heneghana C. et all; Metabolism and Cardiovascular Diseases 2014,24(8),823–836
• 16. Bogdański P., Suliburska J., Szulinska M.; Nutrition Research 2012,32(6),421–427
• 17. Hopkins A. L., Lamm M. G., Funk J. et all; National Institutes of Health 2014
• 18. Hügela H. M., Jacksona N., May B. et all;Phytomedicine 2016,23,220–231
• 19. Znajdek-Awiżeń P., Matławska I.; PostępyFitoterapii 2011,3,197-201
• 20. Khalesi S., Irwin C., Schubert M.; J Nutr 2015,145,758–65
• 21. Ursoniu S., Sahebkar A., Andrica F. et all; Clinical Nutrition 35,2016,615-625
• 22. Caligiuri S. P. B., Edel A. L., Aliani M. et all; Current Hypertension Reports 2014,16,499
• 23. Kohlmunzer S.; PZWL 2000
• 24. Różański H.S.; Essent. Med. 2009(2),32-38,40-51
• 25. Cabrera-Vique C., Navarro-Alarcón M., Martínez C. R.; Nutr Hosp. 2015,32,242-249
• 26. Niedworok J.; Lek w Polsce 1999
• 27. Run-Lan Caia, Lia M., Su-Hua Xieb; Journal of Ethnopharmacology 2011,133(1),177–183
• 28. Lobay D.; Integr Med 2015,14(3),40–46
• 29. Shamon S. D., Perez M. I.; Cochrane Database of Systematic Reviews 2016(12)

• Document Type: minireview